Decode disease mechanisms with RNA-Seq in transcriptome profiling. Discover breakthroughs and invest in precision medicine for personalized treatments.
Biostate AI Raises $12M to Build RNA-Based Foundation Model for Molecular Diagnostics
Biostate AI has raised $12 million in Series A funding to scale its RNA sequencing platform and train a general-purpose AI model capable of predicting disease and therapy response. The round was led by Accel with participation from Gaingels, Mana Ventures,…
Biostate AI Secures $12M in Series A Funding Led by Accel
Biotech startup Biostate AI has raised $12 million in a Series A funding round led by Accel. Gaingels, Mana Ventures, and InfoEdge Ventures joined this funding round with existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures.
Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine
Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult…
Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
The company is reimagining the fragmented reality of molecular research by building the world’s largest RNA sequencing dataset. This dataset will train a general-purpose AI to understand—and eventually guide therapies for—all human diseases.
Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
Biostate AI Raises $12M Series A to Train the ChatGPT of Molecular Medicine
Biostate AI, a molecular diagnostics startup combining next-generation RNA sequencing (RNAseq) with generative AI, announced today it has raised $12 million in a Series A funding round led by Accel.
Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine
Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult…
Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine
Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult…
Revolutionizing Healthcare with Generative AI and RNA Intelligence
Biostate AI is decoding the future of diagnostics through advanced RNA sequencing and AI-powered insights.